Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.535 USD | -2.69% | +2.33% | -5.25% |
Jul. 10 | Theratechnologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2024 | CI |
Jul. 10 | Transcript : Theratechnologies Inc., Q2 2024 Earnings Call, Jul 10, 2024 |
Sales 2024 * | 120M 87.58M | Sales 2025 * | 133M 97.49M | Capitalization | 96.1M 70.23M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | 10M 7.31M | EV / Sales 2024 * | 0.8 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.72 x |
P/E ratio 2024 * |
299
x | P/E ratio 2025 * |
10.8
x | Employees | 103 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.58% |
Latest transcript on Theratechnologies Inc.
1 day | -2.69% | ||
1 week | +2.33% | ||
Current month | +9.64% | ||
1 month | +18.99% | ||
3 months | +14.55% | ||
6 months | -24.75% | ||
Current year | -5.25% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Lévesque
CEO | Chief Executive Officer | 60 | 20-04-05 |
Philippe Dubuc
DFI | Director of Finance/CFO | 57 | 16-02-23 |
Chief Tech/Sci/R&D Officer | 61 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Molson
BRD | Director/Board Member | 56 | 20-10-15 |
Frank Holler
CHM | Chairman | 67 | 21-06-22 |
Director/Board Member | 68 | 17-05-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-17 | 1.535 | -2.69% | 31,799 |
24-07-16 | 1.578 | +2.45% | 140,702 |
24-07-15 | 1.54 | +7.30% | 43,083 |
24-07-12 | 1.435 | -1.03% | 58,068 |
24-07-11 | 1.45 | -3.33% | 90,438 |
Delayed Quote Nasdaq, July 17, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.54% | 100B | |
+11.97% | 43.89B | |
-11.76% | 33.24B | |
+80.35% | 29.36B | |
-12.20% | 16.08B | |
+4.00% | 14.68B | |
-1.90% | 12.87B | |
+178.17% | 10.55B | |
+3.60% | 8.83B |
- Stock Market
- Equities
- TH Stock
- THTX Stock